Tenofovir Alafenamide Succinate

琥珀酸丙酚替诺福韦

Report date: 2026/01/06 13:26:13

Base Information

Drug NameTenofovir Alafenamide Succinate
Drug Alias NameTenofobell-A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReverse transcriptase inhibitorsHBV DNA Polymerase inhibitors
TargetsReverse transcriptaseHBV DNA Polymerase
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsHepatitis B, Chronic
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2023/01/10
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A